Related Experiment Video
Updated: Nov 28, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
Alzheimer's Disease Classification With a Cascade Neural Network
Zeng You1,2, Runhao Zeng2, Xiaoyong Lan1
1Department of Neurology, Shenzhen People's Hospital, The First Affiliated Hospital of Southern University of Science and Technology, The Second Clinical Medical College of Jinan University, Shenzhen, China.
This study introduces a novel two-step neural network for Alzheimer's Disease (AD) classification, combining gait and electroencephalogram (EEG) data for improved accuracy in distinguishing healthy controls (HC), mild cognitive impairment (MCI), and AD patients.
Area of Science:
- Neurology
- Biomedical Engineering
- Artificial Intelligence
Background:
- Alzheimer's Disease (AD) diagnosis is challenging, especially for early detection of mild cognitive impairment (MCI).
- Current methods using only gait or electroencephalogram (EEG) data have limitations, including poor detection of MCI/AD differences or time-consuming data collection and loss of crucial spatial-temporal information.
- Simultaneous analysis of gait and EEG data offers a promising avenue for more accurate and efficient AD classification.
Purpose of the Study:
- To develop a faster and more accurate method for classifying Alzheimer's Disease (AD) by integrating gait and electroencephalogram (EEG) data.
- To improve the detection of mild cognitive impairment (MCI) and differentiate between healthy controls (HC), MCI, and AD stages.
- To leverage the complementary strengths of gait and EEG data for a comprehensive diagnostic approach.
Main Methods:
- A two-step cascade neural network was proposed, utilizing both gait and EEG data.
- The first step employed attention-based spatial-temporal graph convolutional networks on Kinect-captured skeleton sequences (gait) to distinguish HC from patients.
- The second step used spatial-temporal convolutional networks on EEG data to classify patients into MCI or AD categories, preserving spatial and temporal information.
Main Results:
- The proposed method achieved a significantly higher accuracy of 91.07% in the three-way classification (HC, MCI, AD) compared to existing methods (68.18%).
- The study identified the lower body and right upper limb as critical for early AD diagnosis based on gait analysis.
- The integrated approach effectively captured spatial and temporal information from EEG, overcoming limitations of frequency-domain analysis.
Conclusions:
- The novel cascade neural network effectively integrates gait and EEG data for accurate and efficient Alzheimer's Disease classification.
- This method shows significant potential for early detection of MCI and differentiation of AD stages.
- The findings regarding the importance of specific body parts in gait analysis offer valuable insights for clinical research and early AD diagnosis.
More Related Videos
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment
Dementia
The progression of dementia is generally gradual....
Classification of Neurotransmitters
Neural Regulation
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:

